|
Handout
(slide
show | PDF) |
| Speakers |
Cynthia L. Johnson, Pharm.D., ABAT
California Poison Control System, San Diego Division
|
| Location |
Scripps Mercy
Hospital
4077 5th Ave
San Diego, CA 92103
(619) 294-8111
12th Floor (Solarium Room)
|
Map |
| Date |
Wednesday,
July 18th,
2001
6:30-7:00PM - Registration & Dinner
7:00-8:30PM - Program
8:30-8:45PM - Questions & Answers, Certificates |
| Goals |
The
goal of this presentation is to familiarize the participant with commonly
used rave drugs, potentially
serious adverse effects and the treatment of those major adverse effects.
The presentation will also discuss limitations in laboratory
detection of rave drugs.
|
| Objectives |
At
the end of this presentation, the participant should be able to:
- List
commonly used rave drugs.
- State
the proper treatment of GHB withdrawal, recognize important clinical
features and current treatment.
- State
factors that affect the ability to detect many rave drugs in
intoxicated patients.
- List
major toxic effects of ketamine, GHB and MDMA.
- Recognize
potential toxic effects from new designer drugs.
|
| Registration Information |
Pre-Registration: (please return by
July 15th)
- FREE - members of SDCPhA, SDSHP, Pharmacy
Alliance, Students and Technicians
- $10.00 - non-members
On Site Registration:
- $5.00 - members of SDCPhA,
SDSHP, Pharmacy Alliance, Students & Technicians
- $15.00 - non-members
|
|
|
| An AES certificate for 1.0 hour of accredited
continuing education will be awarded the evening of the program
for California pharmacists completing the program. |
| For more
info: John Johnson, PharmD - SDCPhA/SDSHP CE Coordinator, VM. 760-875-7709, email:
education@sdcpha.com, PO Box 83834, San Diego, CA 92138,
FAX 760-875-7709 |
| Program
Supported by _______ |